Related Experiment Video
Updated: Apr 18, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[LDL-apheresis in the treatment familial hypercholesterolemia]
Insights
LDL-apheresis removes LDL-cholesterol via extracorporeal techniques. Studies show beneficial cardiovascular effects in severe hypercholesterolemia, despite ongoing debates on specific indications.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) and elevated lipoprotein(a) are significant cardiovascular risk factors.
- Standard pharmacotherapy may be insufficient for certain severe hypercholesterolemia cases.
- LDL-apheresis offers a targeted extracorporeal approach to cholesterol reduction.
Purpose of the Study:
- To review the indications and efficacy of LDL-apheresis.
- To highlight the cardiovascular benefits of LDL-apheresis in severe hypercholesterolemia.
- To discuss the current landscape of LDL-apheresis techniques and their applications.
Main Methods:
- Review of existing literature and studies on LDL-apheresis.
- Analysis of different selective LDL-cholesterol removal methods.
- Evaluation of clinical outcomes in patients undergoing LDL-apheresis.
Main Results:
- Six selective LDL-cholesterol removal methods are currently available.
- Key indications include homozygous FH, refractory heterozygous FH, and resistant lipoprotein(a) elevation.
- Evidence suggests significant cardiovascular benefits from LDL-apheresis in severe hypercholesterolemia.
Conclusions:
- LDL-apheresis is an effective extracorporeal therapy for specific severe hypercholesterolemia conditions.
- While indications are debated, studies support its cardiovascular benefits.
- Further research and standardized guidelines may refine its therapeutic role.
Abstract:
LDL-apheresis is an extracorporeal elimination technique, which specifically removes LDL-cholesterol from the circulation. There are six methods for the selective LDL-cholesterol removal these days. The main indications for LDL-apheresis are the diagnosis of homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia which is refractory the standard care and intolerance of routine care, and also patients with lipoprotein(a) increase resistant to the farmacotherapy. There is still debate which LDL-cholesterolemia is indication for LDL-apheresis therapy, and the recommendation differs among various countries. Despite large randomized trials are missing, there are several good quality studies to conclude, that the beneficial cardiovascular effects of LDL-apheresis in severe hypercholesterolemia are important and beneficial.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Pharmacogenomics: Identification of New Drug Targets
Lipids: Dietary Sources and Requirements

